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Background: Left ventricular (LV) hypertrophy is a strong predictor of cardiovascular out-
comes, but its genetic regulation remains largely unexplained. Conventional phenotyping
relies on manual calculation of LV mass and wall thickness, but advanced cardiac image
analysis presents an opportunity for high-throughput mapping of genotype-phenotype asso-
ciations in three dimensions (3D). Methods: High-resolution cardiac magnetic resonance
images were automatically segmented in 1,124 healthy volunteers to create a 3D shape model
of the heart. Mass univariate regression was used to plot a 3D effect-size map for the as-
sociation between wall thickness and a set of predictors at each vertex in the mesh. The
vertices where a significant effect exists were determined by applying threshold-free cluster
enhancement to boost areas of signal with spatial contiguity. Results: Experiments on sim-
ulated phenotypic signals and SNP replication show that this approach offers a substantial
gain in statistical power for cardiac genotype-phenotype associations while providing good
control of the false discovery rate. Conclusion: This framework models the effects of genetic
variation throughout the heart and can be automatically applied to large population cohorts.
Availability: The proposed approach has been coded in an R package freely available at
https://doi.org/10.5281/zenodo.834610 together with the clinical data used in this work.
Keywords: imaging-genetics, statistical parametric mapping, computational cardiac atlas.
I. INTRODUCTION
One of the most complex unanswered questions in car-
diovascular biology is how genetic and environmental fac-
tors influence the structure and function of the heart
as a three-dimensional (3D) structure1. This is rele-
vant for understanding the penetrance and expressivity
of variants associated with inherited cardiac conditions as
well as exploring the biology of heart development and
within-population variation. Cardiac magnetic resonance
(CMR) is the gold-standard for quantitative imaging2,
providing a rich source of anatomic and motion-based
data, however conventional phenotyping relies on man-
ual analysis reducing the variables of interest to global
volumes and mass. Computational image analysis, by
which machine learning is used to annotate and segment
the images, is gaining traction as a means of representing
detailed 3D phenotypic variation at thousands of vertices
in a standardized coordinate space (FIG. 1)3,4.
One approach to inference is to transform the spatially-
correlated data into a smaller number of uncorrelated
principal components5, however these modes would not
provide an explicit model relating genotype to pheno-
type. A more powerful approach may be to derive a
statistic expressing evidence of a given effect at each ver-
tex of the 3D model, hence creating a so-called statis-
tical parametric map - a concept widely used in func-
tional neuroimaging6. In this paper we extend techniques
developed in the neuroscience domain to cardiovascu-
lar imaging-genetics by implementing a mass univariate
framework to map associations between genetic variation
and a 3D phenotype. Such an approach would provide
overly-conservative inferences without considering spatial
dependencies in the underlying data and so we validated
the translation of threshold-free cluster-enhancement
(TFCE) to cardiovascular phenotypes for the sensitive
detection of coherent signal7 as well as implementing
robust control for multiple testing. The feasibility of
the proposed methodology to derive computationally-
efficient inferences on imaging-genetics datasets has been
tested through experiments on clinical and synthetic data
using an R package developed for this purpose.
II. METHODS
A. Study population
The healthy volunteers dataset used in this study is
part of the UK Digital Heart Project at Imperial Col-
lege London8 (see Appendix A for full cohort characteris-
tic and acquisition details). To capture the whole-heart
phenotype, a high-spatial resolution 3D balanced steady-
state free precession cine sequence was performed on a
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FIG. 1. Computational image analysis. (A) Short axis
cardiac magnetic resonance image demonstrating automated
segmentation of the endocardial and epicardial boundaries of
the left ventricle. (B) The segmentation is used to construct a
three dimensional mesh of the cardiac surfaces (left ventricle
shown in red, right ventricle in blue) that is co-registered to
a standard coordinate space. Phenotypic parameters, such as
wall thickness, are then derived for each vertex in the model.
1.5-T Philips Achieva system (Best, the Netherlands).
Images were stored on an open-source database (MRIdb,
Imperial College London, UK)9. Conventional volumet-
ric analysis of the cine images was performed using CM-
Rtools (Cardiovascular Imaging Solutions, London, UK)
following a standard protocol10.
Genotyping of common variants was carried out us-
ing an Illumina HumanOmniExpress-12v1-1 single nu-
cleotide polymorphism (SNP) array (Sanger Institute,
Cambridge). Clustering, calling and scoring of SNPs
was performed using Illumina GenCall software. Samples
were pre-phased with SHAPEIT11 and imputation was
performed using IMPUTE212 with the UK10K dataset
as a reference (www.uk10k.org). Quality of the geno-
types was evaluated both on a per-individual and per-
marker level using in-house Perl scripts. SNPs were re-
moved if they had a Impute Information (INFO) score
< 0.4, missing call rate in more than 1% of samples,
minor allele frequency of less than 1% or deviated sig-
nificantly from Hardy-Weinberg equilibrium (p > 0.001).
Only non-related individuals with ”CEU” ethnicity were
retained. The total genotyping rate in these individuals
was 0.997 and the total number of variants available was
9.4 million.
B. Atlas-based segmentation and co-registration
All image processing was performed with Matlab
(MathWorks, Natick, Mass). A validated cardiac seg-
mentation and co-registration framework was used which
has previously been described in detail8,13. A 3D shape
model (at end-diastole and end-systole) was created en-
coding phenotypic variation in our study population at
49,876 epicardial vertices and visualised in a standard
coordinate space (FIG. 1)8. Wall thickness (WT) was
measured by computing the distance between respective
vertices on the endocardial and epicardial surfaces at end-
diastole.
C. Overview of the approach
In the following sections we introduce a framework for
deriving associations between clinical/genetic parameters
and a 3D cardiac phenotype which is outlined in FIG. 2.
Briefly, a general linear model is fitted at each vertex to
extract the regression coefficient associated with the vari-
able of interest (mass univariate regression). Threshold-
free cluster enhancement (TFCE) is then applied to boost
belief in extended areas of coherent signal in the derived
vertex-wise statistical map. The points where a signifi-
cant effect exists are determined by applying TFCE on
the obtained t-statistic map and on N t-statistic maps
obtained through permutation testing, derived under the
null hypothesis of no effect. Then, at each vertex the fre-
quentist probability of having obtained a higher TFCE
score by chance is regarded as the p-value related to the
regression coefficient β. Finally, the derived p-values are
adjusted for multiple testing. The permutation testing
procedure employed by this approach is the Freedman-
Lane procedure14, whilst a false discovery rate (FDR)
correction using the Benjamini-Hochberg procedure15 is
applied to correct for multiple testing.
D. Mass univariate analysis
The association between a ventricular phenotype
mapped onto a 3D mesh and one or more clinical vari-
ables can be described using a general linear model of
the form Y = βX + , where Y is a vector of, for exam-
ple, WT values at each vertex and X is a design matrix
that can be used to model the effect of interest and con-
tains in each column the subject’s values of clinical co-
variates as well as the intercept term. These variables
can be numerical (such as age or weight), categorical
or expressing interaction between them. In particular,
categorical variables can be exploited to express either
different categories (such as gender or ethnicity) or the
presence/absence in a binary form of a clinical condition
(such as the presence of genetic mutation or a specific
disease). β is the regression coefficient vector to be es-
timated and  represents the noise or error term, which
is assumed to be a zero-mean Gaussian process and rep-
resents the variability of Y not explained by the model.
The regression coefficient can be standardized by normal-
izing to mean 0 and unit-variance the columns of X and
Y . As a result, β will represent the amount of variation
of Y in units of its standard deviation when X is in-
creased by one standard deviation, allowing comparisons
between variables.
The same model can be fitted at each ventricular vertex
independently (mass univariate regression) and statistics
can be extracted and corrected for multiple testing in or-
der to test one or more statistical hypotheses. In a para-
metric framework, the t-statistic computed as t = βs.e.(β)
is typically used in the neuroimaging literature to con-
trast the null hypothesis H0 : β = 0 (no association
between the predictor and the phenotype under study),
where s.e.(β) is the standard error of the estimator of
β6. The regression coefficients β and their related p-
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FIG. 2. Outline of three-dimensional mass univariate framework. A statistical atlas provides point-wise measures
of ventricular geometry and function which can be linked to a given predictor through a general linear model. Using mass
univariate regression, three-dimensional maps of a test statistic and the degree of association (β) can be derived. Threshold
free cluster enhancement (TFCE) coupled with permutation testing produces vertex-wise p-values weighted to the degree of
coherent spatial support. Finally, p-values are corrected for multiple testing. Regression coefficients enclosed by significance
contours are represented on a model of the left ventricle.
value thus obtained can be plotted to display, at high
resolution on the whole 3D ventricle, the magnitude and
spatial distribution of a given association. However, this
approach underestimates associations where the signal is
more spatially correlated than noise coherence. For this
reason non-parametric statistics such as TFCE are valu-
able to increase the statistical power of the approach.
E. Threshold-free cluster enhancement on a cardiac atlas
The value of a statistic h obtained through mass uni-
variate regression at a vertex p - a t-statistic in our con-
text - is transformed by TFCE using the following inte-
gral:
TFCE(p) =
∫ hp
h=0
e(h)E hH δh '
hp∑
h=0
e(h)E hH ∆h (1)
In the equation hp is the value of the vertex statistic, e(h)
is the extent of the cluster with cluster-forming thresh-
old h that contains p, and E and H are two parame-
ters usually set to 0.5 and 2 for empirical and analytical
motivations7. In computational algorithms the integral
is estimated using a discrete sum. The computational
model of the heart is defined as a 3D mesh composed of
non-congruent triangles where at each vertex pointwise
phenotypic variables are stored for each subject. The
translation of TFCE to a cardiac model is not straight-
forward as the model is not composed of a regular grid
of voxels (as in brain imaging applications) but instead
forms a mesh of vertices. We addressed this problem by
associating an area to each vertex i equivalent to the
mesh area closest to that vertex. In computing Eq. 1
at each vertex, the most time consuming part is deriving
e(h) - the area of all the elements connected to p that
have a statistic value greater or equal to h - as a different
e(h) needs to be computed for each vertex of the mesh
and for each term of the sum. However, the TFCE score
associated to a vertex p of a specific h in the summa-
tion consists of the same score that should be associated
with all the vertices which contribute to e(h). Therefore,
the computational time of the TFCE method can be sig-
nificantly reduced by sampling the interval between the
maximum and minimum statistic h in the statistic map
so as to use each sampled value as a threshold h˜ for the se-
lection of vertices with a greater statistic value in the case
of positive threshold, or less than h˜ in the case of a neg-
ative threshold. The edges of the graph are defined from
a list containing the nearest neighbours of each vertex,
and which is filtered at each iteration to contain only the
vertices selected by the thresholding operation, resulting
in one or more graphs of connected vertices. In this way,
all the possible patterns of signal on the ventricle can
be discovered without relying on assumptions about the
geometry of cluster shapes. For all the obtained graphs
including more than two vertices the TFCE score can be
computed and associated to all the vertices that belong
to them. The final TFCE score is the sum of all the
TFCE scores thus obtained.
F. Permutation testing
The p-value associated with the regression coefficient
computed at each atlas vertex can be derived via per-
mutation testing. In particular, by permuting N times
the input data, N TFCE scores maps can be obtained.
It is important that the adopted permutation strategy
guarantees the exchangeability assumption, i.e. permu-
tations of Y given X do not alter the joint distribution
of the dependent variables under the null hypothesis. In
the proposed context, the Y values themselves are not ex-
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changeable under the null hypothesis, as the predictors
included in the model together with the variable under
study are nuisance variables that could explain some por-
tion of variability of Y . In order to address this problem,
among a number of available techniques, the Freedman-
Lane procedure14 has proved to provide the best control
of statistical power and false positives (type 1 error)16.
This procedure proceeds as follows. If Z contains all the
nuisance variables previously contained in X, the general
linear model can be rewritten as Y = βX+γZ+. Then,
instead of permuting Y and extracting β, the procedure
computes the residual-forming matrix RZ = 1 − XXT
and performs N different permutations by computing the
model PˆNRZY = βX + γZ +  at each point, where PˆN
is the permutation operator. For a full derivation of the
Freedman-Lane strategy see Winkler et al.16.
G. False discovery rate correction for multiple comparisons
A multiple testing problem arises by testing tens of
thousands of statistical hypotheses simultaneously. Con-
trol of the family wise error rate at 5% could be de-
rived by extracting the maximum score from each map
derived via permutation testing and by using the 95th
percentile as a threshold for significance. However, in
this context such a correction could be overly conserva-
tive as we are rarely interested in the exact number of
vertices that reach significance. The main goal is to de-
tect extended areas of coherent signal and therefore we
can accept a maximum fixed percentage of false discov-
eries as provided by false discovery rate (FDR) proce-
dures. In particular, these procedures can be applied
to adjust the voxelwise p-values obtained at each vertex
by computing the ratio between the number of times in
which a TFCE score greater than the measured one has
been obtained and the number of permutations N . We
have found adaptive procedures such as the two-stage
Benjamini-Hochberg17 not suitable for our dataset, since
it led to lower p-values and increased areas of signifi-
cance, as also reported in the neuroimaging literature18.
For this reason, the original Benjamini-Hochberg (BH)15
procedure has been employed for this work. It is impor-
tant to underline that both FDR correction procedures
are valid when the tested hypotheses are independent or
satisfy a technical definition of dependence called posi-
tive regression dependency on a subset19. This condition
for Gaussian data is translated into the requirement that
the correlation between null voxels or between null and
signal voxels is zero or positive, and for smoothed image
data as those that compose a cardiac atlas, this assump-
tion is generally considered satisfied6.
H. Software
The proposed mass univariate framework has been
coded as an R package (mutools3D) which benefits from
the use of vectorized operations. Matrices containing the
phenotypic data and templates to visualise the 3D mod-
els are also available with the software. Linear regression
assumptions must be met in order to obtain reliable in-
ferences (for a review of them and their importance in
a mass univariate setting see Appendix B). Particularly
important in this context are multicollinearity and het-
eroscedasticity problems which should be checked and
solved for each model definition. For this latter, the R
package implements mass univariate functions exploiting
HC4m heteroscedascity consistent estimators20.
III. RESULTS
A. GWAS Replication Study
As an exemplar application, 6 out of 9 exonic SNPs
which have previously shown an association with LV mass
in a case-control genome wide association study (GWAS),
using echocardiography for phenotyping21, were also
identified in the UK Digital Heart Project genotypes
and were assessed for replication. For each SNP, WT
at each vertex in the 3D model in 1,124 healthy Cau-
casian subjects was tested for association with the pos-
terior estimate of the allele frequency by a regression
model adjusted for age, gender, body surface area (BSA)
and systolic blood pressure (SBP). The tested SNPs are
rs409045, rs6450415, rs1833534, rs6961069, rs10499859
and rs10483186 and cohort characteristics are reported in
Appendix E. Regression diagnosis through Breush-Pagan
and White’s test showed how the homoscedasticity as-
sumption was violated at a large number of vertices,
therefore mass univariate regression was corrected us-
ing HC4m heteroscedascity consistent estimators20. Re-
garding the assumption of multicollinearity, the condition
number of the model matrix was 2.19 while the variance
inflation factor was equal to 1.06, suggesting a very low
degree of multicollinearity. All the simulations were exe-
cuted on a high performance computer (Intel Xeon Quad-
Core Processor (30M Cache, 2.40 GHz), 36Gb RAM),
using the analysis pipeline and R package proposed in
this paper (FIG. 2). A multiple comparisons procedure
correcting for the number of vertices and the number of
SNPs tested was applied by simultaneously testing in a
BH FDR-controlling procedure all the TFCE-derived p-
values from all the models as suggested in22. The number
of permutations was fixed to 10,000 and simulations re-
quired less than 3 hours each. Finally, as a result of a
preliminary study we conducted (full details in Appendix
C ), TFCE parameters E and H were set to 0.5 and 2, as
suggested in the original TFCE paper7, since this choice
provides good sensitivity and specificity on a range of
synthetic signals.
Four SNPs showed a significant association with WT as
reported in FIG. 3. These are rs409045 (maximum re-
gression coefficient β¯ = −0.1, percentage of the LV area
significant S = 13%), rs6450415 (β¯ = −0.11, S = 11%),
rs6961069 (β¯ = −0.09, S = 44%) and rs10499859 (β¯ =
0.1, S = 41%). Conventional linear regression analysis
using LV mass and the same model for all the SNPs did
not reach significance (Appendix E ).
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FIG. 3. Applying three-dimensional analysis to single
nucleotide polymorphism (SNP) replication. On the
left β coefficients are plotted on the surface of the left ventricle
for the effect of rs7183401 on wall thickness (WT) adjusted
for age, gender, body surface area and systolic blood pres-
sure. Yellow contours enclose standardized regression coeffi-
cients reaching significance after multiple testing (FDR-BH)
correction using the full pipeline. Standard mass univariate
regression (MUR) did not provide any significant areas. The
right ventricle is shown in outline for reference. On the right,
the distributions of the derived p-values adjusted for multiple
testing obtained with standard MUR or the proposed pipeline
are shown (the vertical line represents p-value=0.05).
B. Assessment of Sensitivity, Specificity and False
Discovery Rate on Synthetic Data
Sensitivity, specificity and the rate of false discoveries
of the proposed pipeline were estimated using synthetic
data. A 3D model showing no correlation between WT
and the posterior estimate of the allele frequency Xsnp
of an non-associated SNP (rs4288653) adjusted for age,
gender, BSA and SBP was used to generate background
noise. A synthetic data signal was generated by summing
to the WT values of each subject a term I β Xsnp at each
vertex, where I is the signal intensity and β is a map of
regression coefficients. Two contrasting β maps (signal A
and B) obtained from real clinical data were chosen and
are available in Appendix . Signal A was characterized by
non-null β coefficients covering the 10% of total area of
the LV and scaled to the (0,1] range, while signal B pre-
sented non-null regression coefficients scaled to the [-1,0)
range in a more extended area covering the 60% of the LV
surface. By subsampling the number of subjects N and
the signal intensity I, different signals to be detected by
the proposed standard mass univariate pipeline were ob-
tained. The number of permutations for each simulation
was fixed to 5,000 and results were linearly interpolated
and plotted on the contour plots shown in FIG. 4.
Sensitivity increased at larger sample sizes N and signal
intensities I, reaching the greatest values with the most
extended signal (signal B) as expected. Given the sample
size of our GWAS replication study and the intensity of
the associations found, these results would assign a sensi-
tivity of 70% for the first two discovered SNPs and more
than 90% for the other two. Moreover, the rate of false
discoveries was 0 for all the results of signal A and be-
low 5% except for few simulations involving signal B and
sample sizes greater than 1,600 (results reported in Ap-
pendix F ). This effect is due to the large synthetic signal
extension, which causes TFCE to extend its support to
vertices near the true signal which show the same direc-
tion of effect. This is not considered a major limitation
as TFCE will not enhance clusters that originate only
from noise. Finally, sensitivity, specificity and the rate
of false discoveries were also computed using our pipeline
without TFCE - which showed how application of TFCE
provides a relevant increase of up to 50% in sensitivity
which only comes at the expense of a small decrease in
specificity on large extended signals (Appendix F ).
Finally, we have performed a comparative study be-
tween TFCE and a standard cluster-based thresholding
method as reported in the original TFCE paper on brain
imaging data7, which has been implemented in the pro-
posed R package (Appendix D). Overall, in agreement
with the neuroimaging literature, the sensitivity of the
cluster-extent based thresholding method was lower than
TFCE and proved to be very dependent on the cluster-
forming threshold. Moreover, higher false discovery rates
and lower specificities characterised cluster-extent based
thresholding results in all cases when their sensitivity was
comparable or greater than TFCE.
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FIG. 4. Assessment of power using synthetic data. Plots of our framework’s sensitivity at different sample sizes N and
signal intensities I to detect a synthetic signal on A) 10% and B) 60% of the LV surface. A black line on the plots indicates a
threshold of 80% sensitivity.
IV. DISCUSSION
The environmental and genetic determinants of car-
diac physiology and function, especially in the earliest
stages of disease, remain poorly characterized and mor-
phological classification relies on one-dimensional metrics
derived by manual image segmentation23. In contrast,
computational cardiac analysis provides precise 3D quan-
tification of shape and motion differences between disease
groups and normal subjects24. We have extended the ap-
plication of these techniques by designing a general lin-
ear model framework that provides a powerful approach
for modelling the relationship between phenotypic traits,
genetic variation and environmental factors using high-
fidelity 3D representations of the heart. By translating
statistical parametric mapping techniques originally de-
veloped for brain mapping to the cardiovascular domain
we exploit spatial dependencies in the data to identify co-
herent areas of biological effect in the myocardium. This
framework also accounts for multiple testing correction at
tens of thousands of vertices which is the main drawback
of this class of techniques. In particular, the applica-
tion of TFCE leads to a notable increase in power of the
mass univariate approach at the expense of only a slight
increase of the false discovery rate in large extended sig-
nals.
Genetic association studies using conventional 2D imag-
ing leave much of the moderate heritability of LV mass
unexplained25–27. One contribution may be the lack
of phenotyping power of conventional imaging metrics,
which require manual analysis and are insensitive to re-
gional patterns of hypertrophy. Our simulations on syn-
thetic data show that our approach has the power to
detect anatomical regions associated with even small ge-
netic effect sizes. In the reported exemplar application,
we replicated the effect of four SNPs discovered in a
GWAS for LV mass using a 3D WT phenotype with
TFCE applied, while none of the SNPs replicated with
conventional LV mass analysis. The genotype-phenotype
associations that we report reflect that cardiac geometry
is a complex phenotype with a highly polygenic architec-
ture dependent on anatomical patterns of gene expres-
sion and spatially-varying adaptations to haemodynamic
conditions28,29.
One of the main limitations of the presented framework
is that high-spatial resolution CMR is not available in all
cohorts, although conventional two-dimensional images
may be super-resolved to provide similar shape models30.
A second limitation is that the true association may not
be linear in the model parameters and nonlinear mod-
els could better fit the data. However, the advantages
favouring a general linear model are its simplicity, the
ability to easily design and adjust the results for multi-
ple factors and its wide use in biomedical statistics. A
third limitation of this work is with regards to the exper-
iments using synthetic data as we only assessed noise in
our single centre population and did not generalise this to
other cohorts. A general limitation of these approaches
is that they do not establish causal relationships, such as
the interaction between genetic variants, blood pressure
and LV mass, although this may be addressed in future
work by Mendelian randomisation.
Mass univariate approaches do not directly consider the
local covariance structure of the data, however this is ac-
counted for when Random Field Theory or permutation
tests define a threshold for significant activation31. In
the neuroimaging literature, in the context of brain-wide
candidate-SNP analyses, mass univariate approaches are
used more extensively than multivariate approaches as
the latter are less sensitive to regional effects and they
require more observations than the dimension of the re-
sponse variable (i.e. number of vertices) or the use of
dimensionality reduction techniques6.
As the methods are computationally-efficient and require
no human input for phenotypic analysis, it is feasible to
scale up the pipeline to larger population cohorts such
as UK Biobank, which aims to investigate up to 100,000
participants using MR imaging32. Applying these con-
cepts to revealing the effect of rare variants on LV ge-
ometry in participants without overt cardiomyopathy33
and to vertex-wise genome-wide analyses also represent
an interesting area of future work. In this latter context,
multivariate approaches may show promise for modelling
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high-dimensional imaging and genetic data34,35. Finally,
while we have focused on LV geometry and shape, the
same approach can be applied to time-resolved vertex-
wise data to create a functional phenotype for regression
modelling.
V. CONCLUSION
We report a powerful and flexible framework for sta-
tistical parametric modelling of 3D cardiac atlases, en-
coding multiple phenotypic traits, which offers a sub-
stantial gain in power with robust inferences. We have
implemented and validated the approach on both syn-
thetic and clinical datasets, showing its suitability for
detecting genotype-phenotype interactions on LV geome-
try. More generally, the proposed method can be applied
to population-based studies to increase our understand-
ing of the physiological, genetic and environmental effects
on cardiac structure and function.
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APPENDICES
Appendix A: UK Digital Heart Project protocols
Participants who had known cardiovascular or
metabolic disease or were taking prescription medicines
were excluded but simple analgesics, antihistamines, and
oral contraceptives were acceptable. Female subjects
were excluded if they were pregnant or breastfeeding.
Standard safety contraindications to magnetic resonance
imaging were applied including a weight limit of 120 kg.
All subjects provided written informed consent for partic-
ipation in the study, which was approved by a research
ethics committee. Anthropometric measurements were
collected by trained research nurses. Subjects fasted for
four hours before the visit took place. Blood pressure was
acquired in accordance with the guidelines of the Euro-
pean Society of Hypertension36 using a calibrated oscil-
lometric device (Omron M7, Omron Corporation, Ky-
oto, Japan). Five measures were taken, the first three
were discarded and the last two were averaged. Sub-
jects height (Ht) and weight (Wt) were assessed without
shoes and body surface area (BSA) was calculated by the
Mosteller formula: BSA(m2) =
√
Ht(cm)∗Wt(kg)
3600 .
Cardiac MR (CMR) was performed on a 1.5-T Philips
Achieva system (Best, the Netherlands). To capture the
whole-heart phenotype, a high-spatial resolution 3D bal-
anced steady-state free precession cine sequence was used
that assessed the left and right ventricles in their entirety
in a single breath-hold (60 sections, repetition time 3.0
ms, echo time 1.5 ms, flip angle 50◦, field of view 320 ×
320 × 112 mm, matrix 160 × 95, reconstructed voxel size
1.2 × 1.2 × 2 mm, 20 cardiac phases, temporal resolution
100 ms, typical breath-hold 20 s). Images were stored on
an open-source database (MRIdb, Imperial College Lon-
don, UK)9. Conventional volumetric analysis of the cine
images was performed using CMRtools (Cardiovascular
Imaging Solutions, London, UK) following a standard
protocol10.
Appendix B: Gauss-Markov assumptions
In this section we review the statistical assumptions of
the general linear model and their importance in a mass
univariate context, so as to clarify under which conditions
reliable inference can be obtained.
The regression coefficients β in the general linear model
under study can be obtained via ordinary least squares
(OLS): β = (XXT )−1XT y and s.e.(β) =
√
s2(XXT ),
where s2 is the OLS estimate of the variance σ2 of the
observations. According to the Gauss-Markov theorem,
the ordinary least square method will be the best linear
unbiased estimator (BLUE) of the regression coefficients
β if its five assumptions are satisfied. Here we report
the importance of these assumptions for the approach
proposed in this work.
1. No multicollinearity in X. Multicollinearity is
present when a covariate is a linear combination
(perfect) or is highly correlated (imperfect) with
other covariates. The absence of perfect collinear-
ity is necessary to guarantee that X is full rank
so that XXT can be inverted when deriving the re-
gression coefficients, assuring their uniqueness. Im-
perfect multicollinearity results in a reduction of
the statistical efficiency of the derived regression
coefficients, causing a reduction of power and am-
biguous effects37. In order to diagnose this, low
pairwise correlations between predictor variables
are not sufficient to exclude multicollinearity with
more than two explanatory variables, but they are
a necessary condition. The variance inflation fac-
tor and the condition number of the design matrix
can be instead employed to estimate the amount
of variance of each regression coefficient increased
because of collinearity and to detect the amount of
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collinearity respectively38. Taking together these
three latter indices, modifications of the design ma-
trix via omission or orthogonalization of explana-
tory variables can be considered to correct for mul-
ticollinearity.
2. Random sampling of the population. This assump-
tion is required in order to not introduce bias in
the estimates and it is guaranteed when candidates
have been randomly selected to participate to the
study.
3. No endogeneity in X. Endogeneity happens when
an explanatory variable is correlated with the error
term, i.e. E(i|X) 6= 0. In general, this prob-
lem can be due to a model misspecification prob-
lem where one or more predictors have not been
included into the model, to a measurement error
in X that will add bias to the estimation of the
regression coefficients, or to a simultaneity error
when one column of X is jointly determined with
Y. As endogeneity is a conceptual problem, there
are no direct statistical tests to verify this assump-
tion, hence the results should be questioned each
time. In the context under study, the last source of
endogeneity can be considered negligible as imag-
ing and clinical data comes from different sources.
Bias due to measurement errors should be consid-
ered and addressed in the experimental design def-
inition. Finally, the first assumption implies that
the proposed approach can only prove association
and not cause-effect relationships.
4. Linearity and additivity. The relation between de-
pendent and independent variables is required to
be linear in the parameters β, therefore this as-
sumption requires the model covariates to be cor-
rectly specified. More importantly it is required
that the independent variables are additive, i.e. the
amount of change in Y associated with the increase
of one predictor is independent of the values of the
other covariates. This latter assumption guaran-
tees the correct interpretation of the obtained re-
gression coefficients, avoiding their overestimation.
In our context, non-additivity can be addressed by
defining interaction terms of the predictors. More-
over, when interpreting the derived regression coef-
ficients, this assumption highlights again that this
approach only shows the presence of associations
and not cause-effect relationships.
5. Homoscedasticity. This assumption requires that
the error variance σ is identical across observations.
It can be tested by computing a heteroscedasticity
test such as the Breusch-Pagan (for linear het-
eroscedasticity) or the White’s test (for non-linear
heteroscedasticity). Heteroscedasticity causes too
wide or too narrow regression coefficient standard
errors, giving too much weight to certain subsets
of the data when estimating the βs. Important
sources of this effect rely in physiological or
artifactual effects that underlie the measurements
and they can be reduced by using either using
weighted least squares, log transformations of
the data or heteroscedasticity-consistent robust
standard errors.
If assumptions 1-4 are valid the estimation of the re-
gression coefficients are unbiased and consistent, and if 5
is also valid it becomes efficient.
Appendix C: A study on the effect of the TFCE parameters
E and H
The sensitivity of the proposed pipeline using different
values of the TFCE parameters E and H were assessed
using synthetic data. A 3D model showing no correla-
tion between WT and the posterior estimate of the allele
frequency Xsnp of a SNP (rs4288653) adjusted for age,
gender, BSA and SBP was used to generate background
noise. A synthetic data signal was generated by summing
to the WT values of each subject a term I β Xsnp at each
vertex, where I is the signal intensity and β is a map of
regression coefficients. Three distinct β maps (signal 1, 2
and 3) obtained from real clinical data and characterized
by non-null β coefficients scaled to the (0,1] range were
employed (FIG. 5). These covered the 25%, 50% and
75% of total area of the LV respectively were employed
together with three distinct values (0.2, 0.3, 0.4) of sig-
nal intensity I. For a given value of the signal intensity
I and of the spatial extension S of the synthetic signal,
five values of the parameter E and five values of the pa-
rameter H were employed by the proposed framework to
detect the synthetic signal generated (a total of 25 sim-
ulations for each (I,S) couple). The number of subjects
N was fixed to 80, the number of permutations for each
simulation to 5,000. Sensitivity results were linearly in-
terpolated and normalized for the maximum sensitivity
obtained for each (I,S) couple and plotted on the colour
plots reported in FIG. 6.
The first row of FIG. 6 shows the sensitivity results ob-
tained at a fixed spatial extension of the generated syn-
thetic signal (S = 25%) and different signal intensities
I. It can be noticed how at higher signal intensities the
framework sensitivity increases and how on a small ex-
tended signal better sensitivity values are obtained when
H is higher than E. The second row of FIG. 6 shows the
results obtained at a same signal intensity I when in-
creasing the spatial extension S of the generated signal.
In particular, in the bottom left figure it can be noticed
how the importance of the signal intensity I is still pre-
dominant, while with the increase of the signal extension
S the relative importance of the parameter E increases.
In all the studied cases, the false discovery rate of the
framework was always below the 5% and often equal to
0%, while the sensitivity was always above 99%.
Overall, in this preliminary study the values of E = 0.5
and H = 2 suggested in the TFCE original paper7 by the-
oretical and empirical reasons achieved good sensitivity
values. However, the performance of other combinations
of E and H such as (E = 1, H = 3) show promise and
will be investigated in future work.
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Full Cohort (N = 1, 124) Males (N = 511) Females(N = 613)
Age [years] 43.4 ± 13.3 (19-77) 43.2 ± 13.0 (19-77) 43.5 ± 13.2 (20-77)
BSA [m2] 1.84 ± 0.2 1.98 ± 0.16 1.72 ± 0.14
SBP [mmHg] 119.3 ± 14 125.0 ± 12.7 114.65 ± 13.2
TABLE I. A summary of the 1,124 Caucasian subjects of UK Digital Heart Project at Imperial College cohort whose MRI
scans has been used in this work.
beta p-value
rs409045 0.06 0.17
rs6450415 0.01 0.75
rs1833534 -0.05 0.43
rs6961069 -0.01 0.96
rs10499859 0.01 0.84
rs10483186 0.01 0.74
TABLE II. Regression coefficients and their related p-values of the linear association study between LVM and the posterior
estimate of the allele frequency adjusted for age, gender, body surface area (BSA) and systolic blood pressure (SBP) of the
presented GWAS replication study.
Appendix D: A comparison between standard cluster-extent
based thresholding and TFCE
A comparison between the proposed framework using
TFCE and the proposed framework using a standard
cluster-extend based thresholding was performed on the
same synthetic data used in the previous section. The
latter procedure as proposed in39 has been implemented
in the R package developed for this work. This proce-
dure consists of two steps. In the first one, a cluster in
a statistical map obtained by mass univariate regression
is defined as the group of connected vertices that have
a t-statistic value greater than a user-defined threshold
hthr. Then, a second threshold hα is computed via per-
mutation testing as the 95th percentile of the distribution
of largest cluster in each permuted map and used to to
declare significant the clusters in the original statistical
map that are more spatially extended than this threshold
hα. Hence this method depends on the user-defined ini-
tial cluster-forming threshold hthr. For this reason, the
sensitivity, specificity and FDR of the proposed approach
with TFCE parameters E = 0.5 and H = 2 were com-
pared against the results obtained by the same approach
using cluster-extent based thresholding with five distinct
cluster-forming thresholds hthr (0.5, 1, 1.5, 2, 2.5) instead
of TFCE on the five distinct signals studied in the pre-
vious section (FIG. 6). The number of subjects N was
again fixed to 80, the number of permutations for each
simulation to 5,000 and the graphs obtained are reported
in FIG. 7.
The sensitivity of the cluster-extent based thresholding
method proved to be very dependent on the cluster-
forming threshold hthr and its choice had a large im-
pact on the results. Moreover, higher FDR and lower
specificity characterised cluster-extent based threshold-
ing results when their sensitivity was comparable or
greater than TFCE. These results therefore favour the
use of TFCE over cluster-extent based thresholding as
also proved in the brain image analysis literature7.
Appendix E: GWAS replication supplementary data
Table I contains a summary of the covariates employed
in the regression model adopted fr GWAS replication.
Table II reports the results of the linear regression mod-
els used for conventional 2D association analysis between
left ventricular mass (LVM) and the posterior estimate
of the allele frequency of one SNP adjusted for age, gen-
der, body surface area (BSA) and systolic blood pressure
(SBP). Even without multiple testing correction, none of
the models reached significance.
Appendix F: Sensitivity, Specificity and False Discovery
Rate on Synthetic Data
The two regression coefficients (β) maps used to gen-
erate the synthetic data employed in this experiment are
reported in FIG. 8. Signal A covers the 10% of the left
ventricle and has coefficients scaled between 0 and 1,
while signal B covers the 60% of the left ventricle and
has coefficients scaled between -1 and 0.
FIG. 9 reports the two maps obtained on signal A and
B at different signal intensities (I) and sample sizes (N)
for the difference between the sensitivity scored by the
proposed pipeline using TFCE and the sensitivity scored
by the same pipeline without TFCE. The increase of sen-
sitivity provided by TFCE was higher for signal B due to
its larger spatial extension as expected. The difference of
sensitivities converged to zero at high I and N as also the
sensitivity of the pipeline without TFCE reached 100%
sensitivity.
FIG. 10 and FIG. 11 report the detected false discovery
rate (FDR) and specificity of the proposed pipeline with
or without TFCE. In FIG. 10 the FDR of the proposed
pipeline was zero for all the simulated I and N, while it
increased for the second signal (signal B - covering the
60% of the ventricle) and exceeded 5% only for few sim-
ulations having a sample size N greater than 1,600 (one
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example is reported in FIG. 11). This effect is due to the
large synthetic signal extension, which causes TFCE to
reward also the neighbour vertices around the true signal
and it is not considered an issue since it cannot cause to
declare cluster arisen from noise to be significant (as also
shown in FIG. 10).
Overall, the application of TFCE provides a relevant in-
crease in sensitivity which only comes at the expenses of
a little decrease of specificity on largely extended signals.
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FIG. 5. The three regression coefficient β maps (signal 1, 2 and 3) used to generate the synthetic signal to be detected the
method proposed in this paper with different values of the TFCE parameters E and H.
FIG. 6. Colour plots for the proposed framework sensitivity at different TFCE parameters E and H and for different signal
intensities I and signal extension S. In each graph sensitivity values were normalized to the maximum sensitivity detected.
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FIG. 7. Sensitivity, specificity and the false discovery rate (FDR) of the proposed pipeline using either cluster-extent based
thresholding or TFCE at different cluster-forming thresholds (thr). At the top of each set of graphs, the intensity I and the
spatial extension S of the generated synthetic signal is reported.
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FIG. 8. The two β maps used to generate the synthetic data for this experiment - signal A (first row) and B (second row).
FIG. 9. 2D maps showing the increase of sensitivity of the proposed pipeline when TFCE is applied on two different synthetic
signals (A and B) at different signal intensities I and cohort dimensions (N).
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FIG. 10. Signal A. Rate of false discoveries and sensitivity of the proposed pipeline with or without TFCE.
FIG. 11. Signal B. Rate of false discoveries and sensitivity of the proposed pipeline with or without TFCE.
